Physician profile
Richard C Muckerman
NPI 1649219569
$2,163.63
in general payments reported to CMS, 2019-2025
28 companies · $385 in 2025
The $385 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $306 · 2021: $394 · 2022: $286 · 2023: $194 · 2024: $446 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,025.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,024.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $702.07 | 2019-2025 | Evenity, Prolia, Prolia |
| Abbvie INC. | $472.95 | 2019-2025 | |
| Pfizer INC. | $94.93 | 2023-2024 | |
| Therapeuticsmd, INC. | $92.92 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $79.93 | 2021-2025 | |
| Hologic Sales and Service, LLC | $68.44 | 2023-2024 | Thinprep 2000 Processor, Aptima, Third Wave |
| Astellas Pharma US INC | $61.41 | 2019-2024 | Myrbetriq, Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $60.36 | 2024-2025 | |
| Exeltis, USA INC. | $48.93 | 2023-2024 | Slynd |
| Virtus Pharmaceuticals LLC | $48.05 | 2021 | |
| Sumitomo Pharma America, INC. | $42.15 | 2024-2025 | Myfembree |
| Aspira Women'S Health INC | $38.36 | 2022 | |
| Exact Sciences Corporation | $38.20 | 2025 | Cologuard Collection Kit |
| Caldera Medical, INC | $38.16 | 2021-2022 | |
| Agile Therapeutics, INC. | $34.00 | 2021-2024 | Twirla |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $31.24 | 2021 | |
| Glaxosmithkline, LLC. | $30.55 | 2020-2021 | |
| Lilly USA, LLC | $21.50 | 2025 | Zepbound, Mounjaro |
| Medtronic, INC. | $19.87 | 2022 | |
| Allergan, INC. | $18.31 | 2019 | |
| Organon LLC | $18.21 | 2023 | Nexplanon |
| Myriad Women'S Health, INC. | $16.83 | 2023 | Myrisk |
| Mylan Pharmaceuticals INC. | $16.45 | 2021 | |
| Ibsa Pharma INC. | $15.92 | 2022 | |
| Optumhealth Care Solutions, LLC | $14.85 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Smith+Nephew, INC. | $14.28 | 2019 | |
| Coopersurgical, INC. | $13.19 | 2024 | Endosee |
| Radius Health, INC. | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Muckerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.